Promoter Methylation in the Genesis of Gastrointestinal Cancer

키워드

참고문헌 (80)

1. Vogelstein B, "Allelotype of colorectal carcinomas", Science, 244, pp.207~211 (1989)
2. Goel A, "Characterization of sporadic colon cancer by patterns of genomic instability", Cancer Res, 63, pp.1608~1614 (2003)
3. Li R, "Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy", Proc Natl Acad Sci U S A, 통권 : 97, pp.3236~3241 (2000)
4. Lengauer C, "Genetic instability in colorectal cancers", Nature, 386, pp.623~627 (1997)
5. Nishida N, "High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers", Cancer Biol Ther, 6, pp.525~533 (2007)
6. Rodriguez J, "Chromosomal instability correlates with genomewide DNA demethylation in human primary colorectal cancers", Cancer Res, 66, pp.8462~9468 (2006)
7. Sieber OM, "Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC", Proc Natl Acad Sci U S A, 통권 : 99, pp.16910~16915 (2002)
8. Boland CR, "Chromosomal instability and cancer: not just one CINgle mechanism", Gut, 58, pp.163~164 (2009)
9. Muleris M, "Chromosomal instability in near-diploid colorectal cancer: a link between numbers and structure", PLoS ONE, 3, pp.e1632~ (2008)
10. Duval A, "Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency", Cancer Res, 62, pp.1609~1612 (2002)
11. Markowitz S, "Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability", Science, 268, pp.1336~1338 (1995)
12. Rampino N, "Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype", Science, 275, pp.967~969 (1997)
13. Grady WM, "Genomic and epigenetic instability in colorectal cancer pathogenesis", Gastroenterology, 135, pp.1079~1099 (2008)
14. Toyota M, "CpG island methylator phenotype in colorectal cancer", Proc Natl Acad Sci U S A, 통권 : 96, pp.8681~8686 (1999)
15. Herman JG, "Gene silencing in cancer in association with promoter hypermethylation", N Engl J Med, 349, pp.2042~2054 (2003)
16. Yamashita K, "Genetics supersedes epigenetics in colon cancer phenotype", Cancer Cell, 4통권 : 121, pp.131~ (2003)
17. Ahuja N, "Association between CpG island methylation and microsatellite instability in colorectal cancer", Cancer Res, 57, pp.3370~3374 (1997)
18. Kane MF, "Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines", Cancer Res, 57, pp.808~811 (1997)
19. Weisenberger DJ, "CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer", Nat Genet, 38, pp.787~793 (2006)
20. Eads CA, "CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression", Cancer Res, 59, pp.2302~2306 (1999)
21. Samowitz WS, "Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer", Gastroenterology, 129, pp.837~845 (2005)
22. Goel A, "The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer", Gastroenterology, 132, pp.127~138 (2007)
23. Ogino S, "Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma", Am J Surg Pathol, 30, pp.1175~1183 (2006)
24. Tuupanen S, "No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer", Oncogene, 26, pp.2513~2517 (2007)
25. Kaz A, "Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas", Int J Cancer, 120, pp.1922~1929 (2007)
26. Wood LD, "The genomic landscapes of human breast and colorectal cancers", Science, 318, pp.1108~1113 (2007)
27. Nagasaka T, "Methylation pattern of the O6-methylguanine- DNA methyltransferase gene in colon during progressive colorectal tumorigenesis", Int J Cancer, 122, pp.2429~2436 (2008)
28. Forrester K, "Detection of high incidence of K-ras oncogenes during human colon tumorigenesis", Nature, 327, pp.298~303 (1987)
29. Bos JL, "Prevalence of ras gene mutations in human colorectal cancers", Nature, 327, pp.293~297 (1987)
30. Davies H, "Mutations of the BRAF gene in human cancer", Nature, 417, pp.949~954 (2002)
31. Nagasaka T, "Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer", Gastroenterology, 134, pp.1950~1960 (2008)
32. Aaltonen LA, "Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients", Cancer Res, 54, pp.1645~1648 (1994)
33. Tannergård P, "Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer", Hum Genet, 101, pp.51~55 (1997)
34. Esteller M, "DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis", Hum Mol Genet, 10, pp.3001~3007 (2001)
35. Sanchez de Abajo A, "Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?", Oncogene, 25, pp.2124~2130 (2006)
36. Kim WS, "Promoter methylation and down-regulation of DAPK is associated with gastric atrophy", Int J Mol Med, 12, pp.827~830 (2003)
37. Garcia-Manero G, "DNA methylation patterns at relapse in adult acute lymphocytic leukemia", Clin Cancer Res, 8, pp.1897~1903 (2002)
38. Shen L, "DNA methylation and environmental exposures in human hepatocellular carcinoma", J Natl Cancer Inst, 94, pp.755~761 (2020)
39. Nishida N, "Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis", Cancer Res, 67, pp.4586~4594 (2007)
40. Nishida N, "Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma", Hepatology, 47, pp.908~918 (2008)
41. Greger V, "Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma", Hum Genet, 83, pp.155~158 (1989)
42. Robertson KD, "DNA methylation in health and disease", Nat Rev Genet, 1, pp.11~19 (2000)
43. Li E, "Chromatin modification and epigenetic reprogramming in mammalian development", Nat Rev Genet, 3, pp.662~673 (2002)
44. Slattery ML, "Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer", Int J Cancer, 120, pp.656~663 (2007)
45. Samowitz WS, "Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer", J Natl Cancer Inst, 98, pp.1731~1738 (2006)
46. Kaneko Y, "Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas", Gut, 52, pp.641~646 (2003)
47. Maekita T, "High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk", Clin Cancer Res, 12, pp.989~995 (2006)
48. Chan AO, "Cheung HK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation", Gut, 55, pp.463~468 (2006)
49. Perri F, "Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication", Am J Gastroenterol, 102, pp.1361~1371 (2007)
50. Goel A, "Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers", Gastroenterology, 130, pp.1950~1961 (2006)
51. Herath NI, "Review of genetic and epigenetic alterations in hepatocarcinogenesis", J Gastroenterol Hepatol, 21, pp.15~21 (2006)
52. Kang GH, "Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma", Am J Pathol, 160, pp.787~794 (2002)
53. Ohm JE, "A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing", Nat Genet, 39, pp.237~242 (2007)
54. Ohm JE, "Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?", Cell Cycle, 6, pp.1040~1043 (2007)
55. Rashid A, "CpG island methylation in colorectal adenomas", Am J Pathol, 159, pp.1129~1135 (2001)
56. Chan AO, "CpG island methylation in aberrant crypt foci of the colorectum", Am J Pathol, 160, pp.1823~1830 (2002)
57. Shin SK, "Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer", Gastroenterology, 133, pp.1849~1857 (2007)
58. Ahlquist DA, "Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel", Gastroenterology, 119, pp.1219~1227 (2000)
59. Müller HM, "Methylation changes in faecal DNA: a marker for colorectal cancer screening?", Lancet, 363, pp.1283~1285 (2004)
60. Nagasaka T, "Detection of fecal DNA methylation for colorectal neoplasia: does it lead to an optimal screening test?", Acta Med Okayama, 60, pp.249~256 (2006)
61. Chen WD, "Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene", J Natl Cancer Inst, 97, pp.1124~1132 (2005)
62. Zou H, "High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay", Gastroenterology, 136, pp.459~470 (2009)
63. Esteller M, "Epigenetics in cancer", N Engl J Med, 358, pp.1148~1159 (2008)
64. Mitsuno M, "Aberrant methylation of p16 predicts candidates for 5-fluorouracil- based adjuvant therapy in gastric cancer patients", J Gastroenterol, 42, pp.866~873 (2007)
65. Stresemann C, "Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine", Int J Cancer, 123, pp.8~13 (2008)
66. Arnold CN, "Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines", Int J Cancer, 106, pp.66~73 (2003)
67. Oki Y, "Review: recent clinical trials in epigenetic therapy", Rev Recent Clin Trials, 1, pp.169~182 (2006)
68. Kaminskas E, "Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes", Clin Cancer Res, 11, pp.3604~3608 (2005)
69. Hellebrekers DM, "Dual targeting of epigenetic therapy in cancer", Biochim Biophys Acta, 1775, pp.76~91 (2007)
70. Walker DL, "Human papovavirus (JC): induction of brain tumors in hamsters", Science, 181, pp.674~676 (1973)
71. Gordon J, "The human polyomavirus, JCV, and neurological diseases (review)", Int J Mol Med, 1, pp.647~655 (1998)
72. Boland CR, "Infection, inflammation, and gastrointestinal cancer", Gut, 54, pp.1321~1331 (2005)
73. Laghi L, "JC virus DNA is present in the mucosa of the human colon and in colorectal cancers", Proc Natl Acad Sci U S A, 통권 : 96, pp.7484~7489 (1999)
74. Ricciardiello L, "JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract", Gastroenterology, 119, pp.1228~1235 (2000)
75. Jung WT, "JC virus T-antigen expression in sporadic adenomatous polyps of the colon", Cancer, 112, pp.1028~1036 (2008)
76. Enam S, "Ortiz-Hidalgo C, Palazzo JP, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin", Cancer Res, 62, pp.7093~7101 (2002)
77. Casini B, "Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues", Anticancer Res, 25, pp.1079~1085 (2005)
78. Theodoropoulos G, "Assessment of JC polyoma virus in colon neoplasms", Dis Colon Rectum, 48, pp.86~91 (2005)
79. Ricciardiello L, "Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus", Cancer Res, 63, pp.7256~7262 (2003)
80. Goel A, "The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer", Gastroenterology, 132, pp.127~138 (2007)

관련 논문AI추천